3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Gynecologic
3
Breast
2
Thoracic
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
700
Lung Neoplasms
298
Small Cell Lung Carcinoma
149
Colorectal Neoplasms
114
Melanoma
106
Neoplasms
93
Breast Neoplasms
93
Ovarian Neoplasms
92
Neoplasm Metastasis
86
Squamous Cell Carcinoma of Head and Neck
83
Stomach Neoplasms
81
Pancreatic Neoplasms
79
Carcinoma, Renal Cell
66
Triple Negative Breast Neoplasms
63
Esophageal Neoplasms
51
Endometrial Neoplasms
48
Uterine Cervical Neoplasms
47
Head and Neck Neoplasms
47
Mesothelioma
42
Mesothelioma, Malignant
41
Sarcoma
40
Prostatic Neoplasms
36
Urinary Bladder Neoplasms
34
Colonic Neoplasms
32
Carcinoma, Transitional Cell
32
Carcinoma, Hepatocellular
31
Adenocarcinoma of Lung
31
Carcinoma
26
Recurrence
21
Thyroid Neoplasms
20
Interventions
sargramostim
1
pembrolizumab
1
X-Rays
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinosarcoma
×
Thoracic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled